Discussion.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 35, doi. 10.1093/rheumatology/41.S1.35
- Publication type:
- Article
Works matching IS 14620324 AND DT 2002 AND VI 41 AND IP suppl_1
Results: 7
1
2
Arthropathy in art and the history of pain management—through the centuries to cyclooxygenase‐2 inhibitors.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 28, doi. 10.1093/rheumatology/41.S1.28
- By:
- Publication type:
- Article
3
Results from a patient survey to assess gastrointestinal burden of non‐steroidal anti‐inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 23, doi. 10.1093/rheumatology/41.S1.23
- By:
- Publication type:
- Article
4
Clinical experience with cyclooxygenase‐2 inhibitors.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 16, doi. 10.1093/rheumatology/41.S1.16
- By:
- Publication type:
- Article
5
The hidden costs of arthritis treatment and the cost of new therapy—the burden of non‐steroidal anti‐inflammatory drug gastropathy.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 7, doi. 10.1093/rheumatology/41.S1.7
- By:
- Publication type:
- Article
6
The prevalence and burden of arthritis.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 3, doi. 10.1093/rheumatology/41.S1.3
- By:
- Publication type:
- Article
7
Introduction and WHO perspective on the global burden of musculoskeletal conditions.
- Published in:
- Rheumatology, 2002, v. 41, n. suppl_1, p. 1, doi. 10.1093/rheumatology/41.S1.1
- By:
- Publication type:
- Article